Gene · 3811
Papers2,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity. | Cancers (Basel) | 2024 | 39199672 | PubTator, text mining | PubMed |
| Identification of four novel KIR alleles in haematopoietic stem cell donors of Indian origin. | HLA | 2024 | 39162080 | PubTator, text mining | PubMed |
| Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study. | HLA | 2024 | 39148254 | PubTator, text mining | PubMed |
| Orchestrating the Impact of KIR/HLA Interactions on Kidney Transplant. | Int J Mol Sci | 2024 | 39125798 | PubTator, text mining | PubMed |
| LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity. | Cell | 2024 | 39121847 | PubTator, text mining | PubMed |
| Validation of KIR3DL1 alleles assigned by next generation sequencing. | HLA | 2024 | 39022874 | PubTator, text mining | PubMed |
| IFNγ mediates the resistance of tumor cells to distinct NK cell subsets. | J Immunother Cancer | 2024 | 38955423 | PubTator, text mining | PubMed |
| Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder. | Br J Dermatol | 2024 | 38924750 | PubTator, text mining | PubMed |
| Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence. | Front Immunol | 2024 | 38736873 | PubTator, text mining | PubMed |
| Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules. | Structure | 2024 | 38733995 | PubTator, text mining | PubMed |
| IGSF8 is an innate immune checkpoint and cancer immunotherapy target. | Cell | 2024 | 38657602 | PubTator, text mining | PubMed |
| NK cell receptor profiling of endometrial and decidual NK cells reveals pregnancy-induced adaptations. | Front Immunol | 2024 | 38571943 | PubTator, text mining | PubMed |
| HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma. | Immunogenetics | 2024 | 38478091 | PubTator, text mining | PubMed |
| In-depth proteomic analysis identifies key gene signatures predicting therapeutic efficacy of anti-PD-1/PD-L1 monotherapy in non-small cell lung cancer. | Transl Lung Cancer Res | 2024 | 38405006 | PubTator, text mining | PubMed |
| Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer. | Cancers (Basel) | 2024 | 38254876 | PubTator, text mining | PubMed |
| The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia. | Cell Commun Signal | 2024 | 38254135 | PubTator, text mining | PubMed |
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor. | J Exp Clin Cancer Res | 2024 | 38245792 | PubTator, text mining | PubMed |
| Type 1 immunity enables neonatal thymic ILC1 production. | Sci Adv | 2024 | 38232171 | PubTator, text mining | PubMed |
| Association of KIR Genes with Middle East Respiratory Syndrome Coronavirus Infection in South Koreans. | J Clin Med | 2024 | 38202265 | PubTator, text mining | PubMed |
| Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma. | Sci Rep | 2024 | 38184757 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3811/papers?page=4